Zacks Small Cap Has Pessimistic View of LEXX FY2025 Earnings
Lexaria Bioscience Corp. (NASDAQ:LEXX – Free Report) – Zacks Small Cap reduced their FY2025 earnings per share estimates for Lexaria Bioscience in a research note issued on Thursday, April 24th. Zacks Small Cap analyst J. Vandermosten now expects that the company will post earnings of ($0.58) per share for the year, down from their prior […]
